Kimberly-Clark Acquires Kenvue. Here’s What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.

Kimberly-Clark (KMB) closed its $48.7 billion acquisition of Kenvue (KVUE) on Monday, creating a consumer goods and healthcare combination with 10 billion-dollar brands. The deal lands ahead of KMB's Nov. 5 earnings report, the first checkpoint for investors weighing the combined company.

Financing came from two sources: senior notes and the sale of a 51% stake in KMB's paper business to Suzano (SUZ). The notes add leverage, while the paper stake sale converts a portion of the existing portfolio into cash to fund the purchase.

KMB is targeting $2.1 billion in annual synergies within three years. Management also aims to preserve its 54-year Dividend King status through incremental raises. Share buybacks have been suspended, which removes a source of per-share support and signals that cash is being directed toward integration and the dividend. That reading is interpretation, not a stated management rationale.

JNJ is part of the deal's context as a named asset in the classifier set, though the supplied material details no specific JNJ action tied to the transaction.